Navigation Links
WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
Date:12/2/2008

SHANGHAI, China, Dec. 2 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it will dedicate its Philadelphia facility to the Company's expanding biologics testing, cell banking and cell therapy services, and as of December 31, 2008, WuXi will discontinue its U.S. biologics manufacturing operations. In conjunction, approximately 100 biologics manufacturing and supporting positions at the Philadelphia facility will be eliminated through workforce reduction and employee attrition.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

For 2008, WuXi anticipates biologics manufacturing revenues will be less than four percent of total expected annual revenue. Beginning in 2009, WuXi expects to realize approximately $10 million in annual cost savings resulting from this change.

Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, said, "WuXi has been fortunate, even in current market conditions, to continue to experience rapid growth in our global business. This growth reflects our reputation for providing high-quality laboratory services to our clients in a cost-efficient manner. With our continued focus on growth and profitability, we are moving to mitigate operating risks in our biologics manufacturing operations, all of which are based in Philadelphia, and are shifting our Philadelphia-based resources to biologics testing and laboratory services, which continue to show strong customer demand. Our biologics testing, cell banking and cell therapy operations in Philadelphia and our St. Paul and Atlanta operations will be unaf
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
2. WuXi PharmaTech Announces Second Quarter 2007 Results
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
6. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
9. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
10. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
11. WuXi PharmaTech Completes Acquisition of AppTec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ultra-low ... USA, won the Outstanding New Product Award presented on ... and Environmental Repositories (ISBER) at their annual meeting in ... recognizes the company’s development and introduction of the world’s ... was presented to Global Cooling’s CEO Neill Lane by ...
(Date:5/16/2013)... May 16, 2013 Cambridge Healthtech Institute ... August 19-23, 2013 at the Renaissance Waterfront Hotel in ... provide a close-up look at the current strategies and ... bottom-line quality. Leaders in the field will reveal ... produce biopharmaceuticals with greater specificity and efficiency. , “In ...
(Date:5/16/2013)... As the weather warms, women everywhere are waiting for the ... make a statement with fashion, many change their makeup to ... mixes makeup and sweat to produce, and increase acne breakouts. ... warmer months, Adult Acne treatment , Probiotic Action shares ... to deter breakouts. , Recently, an article from ...
(Date:5/16/2013)... 2013 DNA Genotek, a leading provider of ... a sponsorship program in conjunction with the African Society of ... access and reduce the cost of DNA collection ... Human Heredity and Health in Africa (H3 Africa) Initiative and ... aim of the AfSHG is to build the ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Presbyterian Cancer Center - Dallas,a joint venture between ... installed an Elekta Infinity system, enabling the facility ... (VMAT).,Elekta Infinity is the facility,s first image guided ... patients shortened treatment times with,the highest degree of ...
... Dax Denman Join as Company Enters Commercialization Phase, ... developers of,DIRECT TO ETHANOL(TM), the most advanced third ... the company with the,appointments Greg Schlicht as Senior ... Dax Denman as Senior Program Manager., Mr. ...
... Biotech Ltd. (Amex:,SVA), a leading provider of vaccines ... in Ukraine for its inactivated hepatitis A,vaccine, Healive, ... by,Biolik Biopharmaceutical Company, a vaccine manufacturer located in,Kharkov, ... Biolik will,also market and distribute Healive in Ukraine, ...
Cached Biology Technology:Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity 2Presbyterian Cancer Center to Offer Cancer Patients High-End VMAT Treatments With the Installation of Elekta Infinity 3Algenol Biofuels Further Strengthens Team With Key Appointments 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 3
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... 2013, Shenzhen, China---- Why Tibetan antelope can live ... In a collaborative research published in Nature ... other institutes provide evidence that some genetic factors ... harsh highland environments. The data in this work ... mechanisms and the biology of other ruminant species. ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... this innovative solar power technology introduces a new paradigm ... in the world-wide effort to reduce greenhouse gases, it ... source of electricity. Yet several obstacles have been undermining ... actors are looking for a new approach towards the ...
... you want to improve the way you eat, the best way ... visualize yourself carrying it out, according to McGill researchers. ... we,ve known that for a while," says Brbel Knuper of McGill,s ... concrete plan about what they are going to do, they are ...
... method can effectively identify a sub-group of never-smoking lung ... increased risk of disease progression or recurrence, US researchers ... Clinic, Rochester, USA, and colleagues, reported the findings at ... February 2011, Lugano, Switzerland. Approximately 8% - ...
Cached Biology News:Floating solar panels 2Floating solar panels 3Quick, easy test identifies aggressive type of lung cancer in never-smokers 2Quick, easy test identifies aggressive type of lung cancer in never-smokers 3